A follow-up study of chronic complications of hyperuricemia

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200064878

Enrollment

Unknown

Registered

2022-10-20

Start date

2022-10-20

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gout

Interventions

Case series:None

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Inpatient and physical examination population in our hospital; 2. Serum uric acid level >=420umol/L; 3. Aged >=18 years.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating patients; 2. Cancer patients; 3. Patients with uncontrolled mental disorders; 4. Patients with acute ophthalmic inflammation; 5. There are other situations that cannot cooperate.

Design outcomes

Primary

Measure	Time frame
serum urate;	—

Secondary

Measure	Time frame
IL-1ß;	—

Countries

China

Contacts

Public ContactWu Mian

Suzhou Municipal Hospital

wumian320@163.com+86 15121194645

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026